Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc. (MPLT), sold 3,316 shares at $26.61 ($88K) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Open-market sale of $88k MPLT by Chief Discovery Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MPLT | SELL | 2026-04-29 | $1.3M | — | Filing → |